Back to Authors

Malik, S.

Mayo Clinic

St David's Medical Center

Citations 1

DURABLES RESPONSES WITH ANTI‐CD19 ALLOGENEIC CAR T ALLO‐501/501A IN PHASE 1 TRIALS OF RELAPSED/REFRACTORY LARGE B‐CELL LYMPHOMA (R/R LBCL)

Hematological Oncology | June 9, 2023 | Volume: 41 | Issue: S2 | Pages: 85-86

10.1002/hon.3163_48